* indicates required field
Length: 1
Source of Standard: NAACCR/SEER
Section Name: Stage/Prognostic Factors
Year Implemented: 2025
Version Implemented: 25
Record Types: C, A, I, M
XML NAACCR ID: pretextClinicalStaging
Parent XML Element: Tumor
Required Status:
NPCR Collect: . - No recommendations
CoC Collect: . - No recommendations
SEER Collect: RS* - Required, site specific; when available
CCCR Collect: . - No recommendations
Description:
PRETEXT stands for PRE-Treatment Extent of tumor. This field describes the extent of involvement within the four lobes of the liver at time of a pediatric liver tumor diagnosis. It is based off clinical imaging and was originally designed to standardize imaging evaluation and risk stratification of hepatoblastoma before neoadjuvant chemotherapy or tumor resection.
Rationale:
After initially being created by the International Childhood Liver Tumours Strategy Group (SIOPEL) in 1990, PRETEXT was introduced for use within the United States in 2014 by the Children’s Oncology Group (COG) once radiographic imaging became more sophisticated and exploratory surgery at diagnosis was no longer advisable. It is used as a central component of risk stratification schemes that define treatment of hepatoblastoma.
General Notes:
Source documents: imaging
Item Data Type:
numeric
Allowable Values
1-4, 8, 9
Codes:
1 |
One section involved; three adjoining sections are tumor free Stage I, Pretext 1 |
---|---|
2 |
One or two sections involved; two adjoining sections are tumor free Stage 2, Pretext 2 |
3 |
Two or three sections involved; one adjoining section is tumor free Stage 3, Pretext 3 |
4 |
Four sections involved Stage 4, Pretext 4 |
8 |
Not applicable: Information not collected for this case |
9 |
Not documented in medical record Cannot be determined by pathologist PRETEXT not assessed or unknown if assessed |
Code Notes:
Note 1: Effective years
- This SSDI is effective for diagnosis years 2024+
- For cases diagnosed 2018-2023, this SSDI must be blank
Note 2: Criteria for coding
- This SSDI is based on imaging findings only**. Do not** code any findings from surgical resection in this data item. Evaluation must also be done prior to any neoadjuvant therapy
Note 3: Pretext Staging-Segments of the liver
- Caudate liver: Segment I
Note: Involvement of the caudate liver is at minimum Stage 2 - Left lateral section: Segments II & III
- Left medial section: Segments IVA & IVB
- Right anterior section: Segments V & VIII
- Right posterior section: Segments VI & VII